ABSTRACT
INTRODUCTION
Hypertension is defined as persistent elevation of systolic blood pressure of 140 mmHg or greater and/or diastolic BP of 90 mmHg or greater. According to World Health Statistic, it was reported that non-communicable diseases (NCD) were mostly caused by cardiovascular diseases (CVD) which accounted for 31% of global deaths (Mendis 2014) . Hypertension is one of the risk factors for CVD and has been associated with about 17 million deaths annually. It contributes to kidney failure, stroke, heart disease and premature mortality. In the early stage, hypertension is asymptomatic and many people go undiagnosed (WHO 2012) .
Endothelial dysfunction (ED) has been observed in the early stage of hypertension and it is the commonest contributing factor to hypertension (Park & Park 2015) . Several studies had suggested that oxidative stress contributed to the development of hypertension through nitric oxide (NO) inactivation (Baradaran et al. 2014; Sinha & Kumar Dabla 2015) . Increased free radical production as well as imbalance between the level of NO and endothelial vasoconstrictors such as endoperoxides, endothelins and thromboxane A lead to endothelial dysfunction and hypertension (Davidge et al. 2015; Panth et al. 2016; Vanhoutte et al. 2017) .
Many methods to induce hypertension had been used in animal models. N ω -nitro-L-arginine methyl ester hydrochloride (L-NAME), an L-arginine analogue, acts as a competitive inhibitor of non-specific nitric oxide synthases (NOS). L-NAME has been widely used to create NO-deficient hypertensive model. It is well established that inhibition of nitric oxide biosynthesis by in vivo administration of L-NAME causes endothelial dysfunction and vasoconstriction, hence leading to hypertension (Raja 2010) .
Piper sarmentosum is a herb that had been reported to have antioxidant activity (Hafizah et al. 2010) . Toxicity studies on aqueous extract of PS showed that the extract is safe for consumption (Mohd Zainudin et al. 2013) . Previous studies had reported various medicinal effects of PS such as antihyperglycemia (Azlina et al. 2009 ), antiatherosclerosis (Amran et al. 2010) , anticarcinogenesis (Ariffin et al. 2009 ) and antiinflammation (Ridtitid et al. 2007; Zakaria et al. 2010) . Apart from that, PS is also able to protect against glucocorticoid-induced osteoporosis (Mohamad Asri et al. 2016 ) and paracetamol-induced oxidative liver injury (Azlina et al. 2014) . Previous studies had shown that PS is able to reduce blood pressure in spontaneously hypertensive rats (SHR) (Zainudin et al. 2015) . Aqueous extract of PS is able to stimulate NO production in human umbilical vein endothelial cells (HUVECs) (Ugusman et al. 2012) . This suggests that PS may regulate blood pressure via the NO pathway. Therefore, this study was designed to determine the effects of PS on blood pressure, oxidative stress and NO level in L-NAME-induced hypertensive Wistar rats. Thirty six animals were divided into six groups with six animals in each group (n=6): control group; Aqueous extract Piper sarmentosum (AEPS) only group where the rats were given 500 mg/kg/day AEPS via oral gavage; L-NAME-induced hypertensive group was given 100 mg/L L-NAME in drinking water and three groups of L-NAMEinduced-hypertensive rats with co-treatment of different doses of AEPS; 100 mg/L L-NAME and 125 mg/kg/day AEPS; 100 mg/L L-NAME and 250 mg/kg/day AEPS; and 100 mg/L L-NAME and 500 mg/kg/day AEPS. The treatments were given for four weeks (Wheal et al. 2007) . Group 2 was included in this study to investigate whether AEPS on its own could affect the parameters measured in this study. All the three doses of AEPS were adopted from previous study on anti-atherosclerosis effect of AEPS (Amran et al. 2010) .
MATERIALS AND METHODS

PLANT MATERIALS
DETERMINATION OF BLOOD PRESSURE
Systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) were measured in non-anaesthetized rats by non-invasive tail-cuff CODA blood pressure system (Kent Scientific Corporation, USA) at baseline and every two weeks after starting treatment (Zainudin et al. 2015) . At least five readings were recorded during each measurement. The maximum and minimum values were discarded and the remaining three values were calculated as the average (Si & Liu 2008; Yang et al. 2008 ).
BLOOD SAMPLES COLLECTION
Blood samples (2 mL) were obtained in the morning at baseline and at the end of four weeks treatment via retro orbital sinus puncture with the animal under the combination anaesthesia of Zoletil, Xylazil and Ketamine and were collected in plain tubes. The blood samples were centrifuged at 3000 rpm for 10 min to obtain the serum. After the separation, the serum was aspirated and was frozen at -80°C until further experiments.
DETERMINATION OF NITRIC OXIDE LEVEL
Since nitric oxide is unstable in aqueous condition and has a short half-life, the level of its stable metabolites, nitrite (NO 2 -) and nitrate (NO 3 -) was measured based on Griess method using QuantiChrom TM nitric oxide assay kit (BioAssay Systems, USA) according to the manufacturer's instructions. Total NO 2 -/NO 3 -in the serum samples were quantitated by measuring the optical density at 540 nm.
The lipid peroxidation indicator, plasma MDA was measured using thiobarbituric acid reactive substances (TBARS) assay as described previously (Borges et al. 2018) . Total protein concentration in the serum was measured using protein biuret reaction (Pessoa et al. 2017 (Arora et al. 2009 ). Increased in free radical generation inactivates prostacyclin and NO, hence causing half-life of prostacyclin and NO to be decreased. This situation may lead to increase in peripheral vascular resistance and subsequently hypertension (Kumar & Das 1993) . Basal production of NO was reduced in spontaneously hypertensive rats (SHR) (Dohi et al. 1990 ).
The endothelium-dependant vasodilator responses were attenuated in patients who suffered from essential hypertension which was mainly contributed to reduced bioactivity of NO (Panza et al. 1990 ).
The main objective in this study was to evaluate whether the high blood pressure in NO-deficient hypertensive rats induced by L-NAME, an L-arginine analogue that inhibits nitric oxide synthases could be improved by AEPS treatment. In the present study, the administration *p<0.001 versus L-NAME, # p<0.05 versus pre-treatment FIGURE 4. Effect of AEPS on serum NO in L-NAME-induced-hypertensive rats *p<0.001 vs L-NAME; # p<0.05 vs L-NAME; + p<0.01 vs pre-treatment FIGURE 5. Effect of AEPS on serum MDA level in L-NAME induced-hypertensive rats of L-NAME in drinking water had induced hypertension in rats which concurred with previous studies (Raja 2010) . Concomitant treatment with serial doses of AEPS in the L-NAME-induced hypertensive rats had significantly attenuated the hypertension. Nitric oxide produced by endothelial nitric oxide synthase (eNOS) is the major source of circulating NO. L-NAME interferes with the activity of eNOS, thus reducing NO production (Raja 2010) . Since NO is a potent vasodilator, decreased NO production may impair endothelial-dependent vasodilation, causing increased peripheral resistance and blood pressure (Park & Park 2015) . Previous study had proven that PS increased NO level by stimulating eNOS expression and activity in HUVECs (Ugusman et al. 2010) . Therefore, increased level of NO in L-NAME-induced hypertensive rats treated with AEPS could be due to increase in the activity of eNOS. A study by Ugusman et al. (2014) had found that a flavonoid, rutin, one of the compound in Piper sarmentosum, may improve endothelial function by augmenting NO production in HUVEC. Another recent study on PS showed that the extract was able to reduce blood pressure by increasing NO production in SHR (Zainudin et al. 2015) .
Apart from inhibiting NO synthesis, L-NAME induces hypertension by causing oxidative stress. L-NAME is responsible to cause imbalance in renin-angiotensin system (RAS) whereby it increased the expression of angiotensin II and also caused renal dysfunction (Rincon et al. 2015) . The excessive production of angiotensin II leads to increase vascular superoxide (O 2 -) formation through increased expression of NADPH-dependent oxidase in aortic smooth muscle cells (Tsai et al. 2016) . The excessive O 2 -react rapidly with NO to form peroxynitrite (ONOO − ). Peroxynitrite is a strong pro-oxidant molecule which causes lipid peroxidation and tissue injury (Hogg et al. 2017 ). In addition, hypertension itself leads to enhanced production of ROS. Previous studies had shown that in different models of systemic hypertension, there would be enhancement of O 2 -and superoxide-producing enzymes, regardless of how the hypertension was induced (Drummond & Sobey 2014; García-Redondo et al. 2016) . Malondialdehyde exists in the serum, plasma, tissues as well as in the urine. It is the commonest analytic estimation of lipid peroxidation and oxidative stress that has been reported (Chen et al. 2015) . In the present study, the level of MDA was increased in the L-NAME-induced hypertensive rats; indicating that oxidative stress plays an important role in the pathophysiology of hypertension (Baradaran et al. 2014 ). Treatment of L-NAME-induced hypertensive rats with AEPS caused reduction in MDA level. This finding is in accordance to a recent study which showed that PS significantly reduced MDA level in spontaneously hypertensive rats (Zainudin et al. 2015) .
Decreased level of MDA in AEPS treated group could be attributed to the antioxidant effects of PS. PS had been proven to have strong antioxidant activity (Ugusman et al. 2012) . Besides, PS had been shown to suppress intercellular adhesion molecule-1 (ICAM-1) and NADPH oxidase 4 (Nox4) expressions in oxidative stress-induced HUVECs. Nox4 is the predominant enzyme for ROS production in endothelial cells (Ugusman et al. 2010) . Several chemical compounds with antioxidant activities found in PS are polyphenols, vitamins C and E, carotenes, tannins, xanthophylls, flavonoids and amides (Hussain et al. 2015) . Polyphenols had been shown to reduce blood pressure in NO-deficient model of hypertension (Bernátová et al. 2002; Rodrigo et al. 2016) . Since this study used crude extract of PS and not its isolated bioactive components, this study was unable to specify the active compound responsible for the antihypertensive effect. However, it is suggested that the antihypertensive effect of PS in NO-deficient model of hypertension observed in this study is due to its polyphenols content.
CONCLUSION
AEPS reduces blood pressure in L-NAME-induced hypertensive rats and the antihypertensive effect may be partly mediated by increased NO and reduced oxidative stress. Our findings suggest that AEPS has the potential to be developed as a therapeutic agent for hypertension. However, further studies using isolated bioactive components from AEPS are required in order to support the therapeutic potential of AEPS for hypertension.
